IL1B serves as the second-tier mechanism of HFD+CKD-promoted TI, promotes TI gene expression, and enhances Casp4–induced VCAM-1 expression and IL1B secretion in HAECs. The gene discussed is IL1B; the disease is chronic kidney disease.